Sulzer Looking To Double Medical Device Revenues Over Next Two Years
This article was originally published in The Gray Sheet
Executive Summary
Sulzer says it plans to roughly double the size of its core cardiovascular/orthopedic device and materials technology businesses within two years to approximately $2 bil. and at the same time maintain a "significant focus" on biotechnology.